T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.71% |
| 2 | Healthcare | 16.11% |
| 3 | Consumer Discretionary | 15.3% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Under Armour
UAA
$2.3B
| $5.99M | ﹤0.01% |
282,966
-11,100
| -4% | -$247K |
|
|
AXON
1477
Axon Enterprise
AXON
$49.6B
| $5.97M | ﹤0.01% |
33,742
-1,864
| -5% | -$274K |
|
|
CCXI
1478
DELISTED
ChemoCentryx, Inc.
CCXI
| $5.96M | ﹤0.01% |
444,898
+8,622
| +2% | +$212K |
|
1479
Barings BDC
BBDC
$977M
| $5.92M | ﹤0.01% |
560,585
+176,800
| +46% | +$1.85M |
|
|
ORTX
1480
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $5.89M | ﹤0.01% |
134,286
-667
| -0.5% | -$37.2K |
|
1481
Annaly Capital Management
NLY
$17.6B
| $5.86M | ﹤0.01% |
165,018
-13,555
| -8% | -$492K |
|
1482
GameStop
GME
$8.37B
| $5.74M | ﹤0.01% |
107,284
+7,336
| +7% | +$356K |
|
1483
Patria Investments
PAX
$1.85B
| $5.69M | ﹤0.01% |
322,806
+15,400
| +5% | +$246K |
|
1484
WillScot Mobile Mini Holdings
WSC
$4.36B
| $5.66M | ﹤0.01% |
202,984
-17,372
| -8% | -$499K |
|
1485
Sunrun
RUN
$2.44B
| $5.57M | ﹤0.01% |
99,925
+4,552
| +5% | +$220K |
|
1486
Under Armour Class C
UA
$2.25B
| $5.51M | ﹤0.01% |
296,520
-2,690
| -0.9% | -$50.7K |
|
1487
Gaming and Leisure Properties
GLPI
$12.7B
| $5.49M | ﹤0.01% |
118,508
-2,520
| -2% | -$116K |
|
1488
Royal Bank of Canada
RY
$299B
| $5.4M | ﹤0.01% |
53,253
-9
| -0% | -$892 |
|
|
PSTH.WS
1489
DELISTED
Pershing Square Tontine Holdings, Ltd. Warrants, exercisable for one share of Class A Common Stock f
PSTH.WS
| $5.37M | ﹤0.01% |
851,688
| – | – |
|
1490
US Foods
USFD
$23.7B
| $5.32M | ﹤0.01% |
138,777
-12,011
| -8% | -$466K |
|
1491
Lear
LEA
$8.29B
| $5.3M | ﹤0.01% |
30,230
-2,215
| -7% | -$410K |
|
1492
Oshkosh
OSK
$9.48B
| $5.23M | ﹤0.01% |
41,931
+1,437
| +4% | +$182K |
|
1493
Axalta
AXTA
$7.96B
| $5.21M | ﹤0.01% |
170,976
-1,969
| -1% | -$62.3K |
|
1494
TIM SA
TIMB
$8.29B
| $5.21M | ﹤0.01% |
452,400
| – | – |
|
1495
Teva Pharmaceuticals
TEVA
$42.8B
| $5.13M | ﹤0.01% |
517,830
+407,900
| +371% | +$4.32M |
|
1496
UGI
UGI
$7.57B
| $5.1M | ﹤0.01% |
110,039
+11,177
| +11% | +$503K |
|
1497
Nordson
NDSN
$17.2B
| $5.08M | ﹤0.01% |
23,132
-1,732
| -7% | -$367K |
|
1498
Ciena
CIEN
$60.4B
| $5.07M | ﹤0.01% |
89,091
-2,922
| -3% | -$161K |
|
1499
Jazz Pharmaceuticals
JAZZ
$15.8B
| $5.03M | ﹤0.01% |
28,315
+3,412
| +14% | +$591K |
|
1500
Wyndham Hotels & Resorts
WH
$5.46B
| $4.98M | ﹤0.01% |
68,922
-2,240
| -3% | -$165K |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.